• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Distinct clinicopathological features of neuroendocrine liver metastases originating from the pancreas and rectum.胰腺和直肠来源的神经内分泌肝脏转移的不同临床病理特征。
World J Surg Oncol. 2024 Aug 3;22(1):209. doi: 10.1186/s12957-024-03476-5.
2
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database.一种预测神经内分泌肝转移患者肝切除术后预后的新型列线图:来自意大利神经内分泌肝转移数据库的分析
J Gastrointest Surg. 2017 Jan;21(1):41-48. doi: 10.1007/s11605-016-3228-6. Epub 2016 Aug 8.
3
Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.手术切除可改善神经内分泌肿瘤肝转移患者的预后:来自亚洲的大数据
Medicine (Baltimore). 2015 Jan;94(2):e388. doi: 10.1097/MD.0000000000000388.
4
Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.晚期胰腺神经内分泌肿瘤的外科治疗:一项国际多机构研究的短期和长期结果
Ann Surg Oncol. 2015 Mar;22(3):1000-7. doi: 10.1245/s10434-014-4016-8. Epub 2014 Sep 5.
5
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.神经内分泌肝脏转移:原发肿瘤部位对接受根治性肝切除术患者的预后影响。
J Gastrointest Surg. 2017 Dec;21(12):2039-2047. doi: 10.1007/s11605-017-3491-1. Epub 2017 Jul 25.
6
Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.晚期胰腺神经内分泌肿瘤的多学科治疗策略——单中心经验
Hepatogastroenterology. 2012 Nov-Dec;59(120):2623-6. doi: 10.5754/hge12116.
7
Management of neuroendocrine tumor liver metastases.神经内分泌肿瘤肝转移的治疗管理。
Am J Surg. 2023 Nov;226(5):623-630. doi: 10.1016/j.amjsurg.2023.08.011. Epub 2023 Aug 16.
8
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.影响 G1 和 G2 级胃肠胰神经内分泌肿瘤初始 R0 手术切除后肝转移瘤患者预后的风险因素。
BMC Cancer. 2019 Apr 8;19(1):335. doi: 10.1186/s12885-019-5457-z.
9
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.神经内分泌肝脏转移患者肝切除范围的影响:一项国际多机构研究。
J Gastrointest Surg. 2019 Mar;23(3):484-491. doi: 10.1007/s11605-018-3862-2. Epub 2018 Jul 6.
10
Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.全胰切除术和肝移植治疗胰腺转移性神经内分泌肿瘤——单中心10例患者的经验
Langenbecks Arch Surg. 1999 Aug;384(4):370-7. doi: 10.1007/s004230050216.

引用本文的文献

1
Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas.胃肠道混合性神经内分泌非神经内分泌肿瘤及纯神经内分泌癌管理的关键考量因素
World J Gastrointest Oncol. 2024 Dec 15;16(12):4559-4564. doi: 10.4251/wjgo.v16.i12.4559.

本文引用的文献

1
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.欧洲神经内分泌肿瘤学会(ENETS)2023 年无功能性胰腺神经内分泌肿瘤指南。
J Neuroendocrinol. 2023 Dec;35(12):e13343. doi: 10.1111/jne.13343. Epub 2023 Oct 25.
2
Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies.经导管动脉栓塞术治疗不同血供相关肝转移神经内分泌肿瘤患者
Cancer Med. 2023 Sep;12(18):18578-18587. doi: 10.1002/cam4.6464. Epub 2023 Aug 17.
3
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.欧洲神经内分泌肿瘤学会(ENETS)2023 年结直肠神经内分泌肿瘤指南。
J Neuroendocrinol. 2023 Jun;35(6):e13309. doi: 10.1111/jne.13309. Epub 2023 Jun 22.
4
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.欧洲神经内分泌肿瘤学会(ENETS)2023年消化神经内分泌癌指南文件
J Neuroendocrinol. 2023 Mar;35(3):e13249. doi: 10.1111/jne.13249. Epub 2023 Mar 16.
5
Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.胃肠胰神经内分泌肿瘤患者的长期生存:一项基于人群的研究。
Eur J Cancer. 2022 Sep;172:252-263. doi: 10.1016/j.ejca.2022.06.003. Epub 2022 Jul 6.
6
The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases.原发性肿瘤切除在伴有肝转移的胰腺神经内分泌肿瘤患者中的作用
Front Oncol. 2022 Mar 8;12:838103. doi: 10.3389/fonc.2022.838103. eCollection 2022.
7
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.过去 20 年胰腺神经内分泌肿瘤的生存和发病模式:一项 SEER 数据库分析。
Oncologist. 2022 Jul 5;27(7):573-578. doi: 10.1093/oncolo/oyac049.
8
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.《2022 年世卫组织神经内分泌肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16.
9
Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases.胰腺神经内分泌肿瘤淋巴结复发后重复淋巴结清扫术的长期生存:两例报告
J Surg Case Rep. 2021 Oct 13;2021(10):rjab446. doi: 10.1093/jscr/rjab446. eCollection 2021 Oct.
10
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.奥沙利铂联合氟尿嘧啶治疗高级别分化型消化道神经内分泌肿瘤:法国神经内分泌肿瘤研究组的一项多中心回顾性研究。
Neuroendocrinology. 2022;112(6):537-546. doi: 10.1159/000518650. Epub 2021 Jul 26.

胰腺和直肠来源的神经内分泌肝脏转移的不同临床病理特征。

Distinct clinicopathological features of neuroendocrine liver metastases originating from the pancreas and rectum.

机构信息

Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.

Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo City, 060-8638, Japan.

出版信息

World J Surg Oncol. 2024 Aug 3;22(1):209. doi: 10.1186/s12957-024-03476-5.

DOI:10.1186/s12957-024-03476-5
PMID:39097743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11297738/
Abstract

INTRODUCTION

Survival comparisons among patients with liver metastases from pancreatic and rectal neuroendocrine tumors (NETs) were limited, and the efficacy of observation rules in patients undergoing hepatectomy for neuroendocrine liver metastases (NELMs) was unknown. This study aims to distinguish these characteristics and clarify the effects of the observation rules on NELMs.

METHODS

Clinical data were separately collected from patients with pancreatic and rectal NELMs at medical centers in both Japan and China. The Japanese cohort followed the observation rules for the resection of NELMs. A comparative analysis was conducted on clinical characteristics and prognosis features such as overall survival time (OS) and disease-free survival interval (DFS-I).

RESULTS

Enrollment included 47 and 34 patients from Japan and China, respectively. Of these, 69 and 12 patients had tumors originating from the pancreas and rectum, respectively. The OS time in patients undergoing primary tumor resection was significantly longer; however, the OS time between the patients undergoing and not undergoing radical resection of liver metastasis was the same. In asynchronous NELMs, patients with rectal (R)-NELMs showed a significantly higher proportion of type III NELMs. Additionally, the median DFS-I of asynchronous R-NELMs was longer than the recommended follow-up time, with 71.4% of them classified as G2. In the Japanese cohort, patients who adhered to the observation rules exhibited a longer median DFS after hepatectomy for NELMs compared with their counterparts.

CONCLUSION

Although curative surgery is crucial for primary lesions, personalized approaches are required to manage NELMs. Extended overall follow-ups and shortened follow-up intervals are recommended for G2 stage rectal NETs. The observation rules for NELMs require further validation with a larger sample size.

摘要

简介

胰腺和直肠神经内分泌肿瘤(NETs)肝转移患者的生存比较有限,且神经内分泌肝脏转移瘤(NELMs)患者行肝切除术后的观察规则的疗效尚不清楚。本研究旨在区分这些特征,并阐明观察规则对 NELMs 的影响。

方法

分别从日本和中国的医学中心收集胰腺和直肠 NELMs 患者的临床数据。日本队列遵循 NELMs 切除术的观察规则。对总生存时间(OS)和无病生存间隔(DFS-I)等临床特征和预后特征进行比较分析。

结果

共纳入日本和中国的 47 例和 34 例患者,其中 69 例和 12 例患者的肿瘤来源于胰腺和直肠。行原发肿瘤切除术的患者 OS 时间明显延长,但行和未行肝转移根治性切除术的患者 OS 时间相同。在异步 NELMs 中,直肠(R)-NELMs 患者 III 型 NELMs 比例明显较高。此外,异步 R-NELMs 的中位 DFS-I 长于推荐的随访时间,其中 71.4%的患者为 G2 期。在日本队列中,与未遵守观察规则的患者相比,遵守观察规则的患者在接受 NELMs 肝切除术后的中位 DFS 更长。

结论

尽管根治性手术对原发灶至关重要,但需要针对 NELMs 采用个体化方法。建议对 G2 期直肠 NETs 进行更长期的全面随访和缩短随访间隔。需要进一步验证 NELMs 的观察规则,样本量更大。